CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies 6,8-bis(benzylthio)octanoic acid in treating patients with
locally advanced or metastatic pancreatic cancer. Drugs used in chemotherapy, such as
6,8-bis(benzylthio)octanoic acid, work in different ways to stop the growth of tumor cells,
either by killing the cells or by stopping them from dividing.